Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
Status:
Completed
Trial end date:
2009-08-28
Target enrollment:
Participant gender:
Summary
GSK1034702 is being developed for improving cognitive impairment in diseases such as
Alzheimer's disease and schizophrenia. This study will be done in healthy men to investigate
how much of the study drug gets into the brain. This will be done using Positron Emission
Tomography (PET).